Skip to content

White Matter Plasticity in Schizophrenia

White Matter Plasticity in Schizophrenia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06641297
Enrollment
36
Registered
2024-10-15
Start date
2025-01-02
Completion date
2026-12-31
Last updated
2026-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia Disorders

Keywords

music, training, plasticity

Brief summary

Schizophrenia spectrum disorders are associated with impairment in the microstructure of white matter, the key brain tissue responsible for fast communication between different brain regions necessary for any complex task. This white matter impairment is linked to problems with cognition in schizophrenia, especially slower processing speed. This project aims to study the potential for correcting white matter deficits in schizophrenia by examining mechanisms underlying white matter structure changes in response to training on playing a mock musical instrument.

Interventions

BEHAVIORALMusic video game

The video game \'Guitar Hero\' will be used as the platform for training for participants to acquire a new \'skill\'

Sponsors

University of Maryland, Baltimore
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
15 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder, or psychosis NOS * age 15-45 * able to provide informed consent

Exclusion criteria

* contraindications to MRI (metal implants, claustrophobia) * medical condition that limits use of hands (ie, arthritis) * Active or recent (within 6 months) substance use disorder other than nicotine

Design outcomes

Primary

MeasureTime frameDescription
White matter microstructure3 weeksfractional anisotropy of white matter tracts as assessed with diffusion tensor imaging

Secondary

MeasureTime frameDescription
Brain level of N-acetylaspartate3 weeksNAA levels in motor cortex of brain as measured with magnetic resonance spectroscopy

Countries

United States

Contacts

CONTACTJoshua J Chiappelli, MD
jchiappe@som.umaryland.edu4104026827

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026